Free Newsletter
FDA opens doors in Costa Rica
A year after announcing plans to open offices overseas--part of the "Beyond Our Borders Initiative," the FDA has a site in Brussels, three offices in China and has now officially opened its doors in San José, Costa Rica. The agency began plans for the office in Latin American in June 2008 following a summit in El Salvador with Health Ministers from the Central American region. The FDA expects to further expand its presence into Latin America with another office in Mexico and South America later this year.
"The countries of Central America, along with Panamá and the Dominican Republic, create the third-largest U.S. export market in Latin America, and, every year, the United States imports millions of dollars in goods from these important trade partners," Secretary Leavitt said. "An HHS/FDA presence in the region will improve collaboration, strengthen our partnership and hasten the flow of quality goods to our markets."
The FDA also has plans to open two more offices in India and is "pursuing options" in the Middle East region.
- view the HHS/FDA release
- read more from Inside Costa Rica
Related Articles:
Overseas oversight gets serious - FDA trends
FDA wants satellite offices overseas
Can FDA ever safeguard China-made meds?
FDA weak on foreign pharma plant oversight
GAO assails FDA's foreign inspections
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: